Ursodeoxycholic acid does not reduce SARS-CoV-2 infection in newly allogeneic hematopoietic stem cell transplantation recipients: a prospective NICHE cohort

IntroductionRetrospective studies have suggested that Ursodeoxycholic Acid (UDCA) provide a protective effect against SARS-CoV-2 infection, particularly in patients with liver disease. However, it is uncertain whether this finding can be extended to the allogeneic hematopoietic stem cell transplanta...

Повний опис

Бібліографічні деталі

Автори:	Hongye Gao, Jiali Wang, Xinhui Zheng, Xiaolei Pei, Yawei Zheng, Weihua Zhai, Rongli Zhang, Xin Chen, Qiaoling Ma, Jialin Wei, Donglin Yang, Aiming Pang, Yi He, Sizhou Feng, Yigeng Cao, Erlie Jiang
Формат:	Artigo
Мова:	Inglês
Опубліковано:	Frontiers Media S.A. 2024-03-01
Серія:	Frontiers in Cellular and Infection Microbiology
Предмети:	Ursodeoxycholic acid hematopoietic stem cell transplantation SARS-CoV-2 prevention and control cohort studies
Онлайн доступ:	https://www.frontiersin.org/articles/10.3389/fcimb.2024.1324019/full
Теги:	Додати тег Немає тегів, Будьте першим, хто поставить тег для цього запису!